Luis Alberto García Rodríguez

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study

F. D. de Abajo, D. Montero, Luis Alberto García Rodríguez, 1999, BMJ.

NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population

Marta L. Capone, S. Tacconelli, P. Patrignani, 2010, Pharmacological reports : PR.

The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

J. Castellsagué, S. Perez-Gutthann, C. Varas‐Lorenzo, 2009, Pharmacoepidemiology and drug safety.

Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model

Á. Lanas, K. Bollaerts, R. Langley, 2021, International journal of cardiology. Heart & vasculature.

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

K. Khunti, N. Tangri, J. Eriksson, 2021, Cardiovascular Diabetology.

Cardiovascular Safety of Non-Steroidal Anti-Inflammatory Drugs. Lights and Shadows

L. Rodríguez, Antonio González-Péreza, Luis Alberto García Rodríguez, 2007 .